Subcutaneous Panniculitis-Like T-Cell Lymphoma with Hemophagocytic Syndrome in a Child: A Successful Treatment with the BFM-NHL-90 Protocol
	    		
		   		
		   			
		   		
	    	
    	 
    	10.15264/cpho.2020.27.2.129
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Sunjoo KIM
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Aeri KIM
			        		
			        		;
		        		
		        		
		        		
			        		Jeong Ok HAH
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Departments of Pediatrics, Daegu Fatima Hospital, Daegu, Korea
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:CASE REPORT
 
        	
        	
            
            
            	- From:Clinical Pediatric Hematology-Oncology
	            		
	            		 2020;27(2):129-133
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:Korean
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	 Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a distinct cutaneous lymphoma subtype that is characterized by pleomorphic T-cell infiltration of the subcutaneous tissue. SPTCL is usually associated with indolent clinical course. However, it can be complicated by hemophagocytic syndrome (HPS), which leads to worse prognosis. Childhood SPTCL is rare and there is no standardized treatment regimen of SPTCL with HPS. Here we report a pediatric case of SPTCL with HPS who responded favorably with multi-agent chemotherapy of the BFM (Berlin‐Frankfurt‐Münster)-NHL (non-Hodgkin lymphoma)-90 protocol.